LONG BEACH, Calif. (KABC) -- Many people experience occasional acid reflux. But if you have it all the time, it could lead to a very serious condition and in some cases, cancer. Now, there's a new ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the latest American ...

FULLERTON, Calif. (KABC) -- The latest findings reveal esophageal cancer rates are up across the board. Many factors can raise your risk, including your line of work. A recently FDA-approved, ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present new data supporting the ability ...

The MarketWatch News Department was not involved in the creation of this content. AURORA, Colo., Oct. 08, 2025 (GLOBE NEWSWIRE) -- EnteroTrack LLC announced that the Centers for Medicare & Medicaid ...

Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the ...

FORT WORTH, Texas — Over the last two weeks, Fort Worth firefighters have been taking a few minutes out of their shift to screen for esophageal cancer using a new test. "When this was something that ...

ProPhase Labs Inc (NASDAQ:PRPH) saw its stock jump 38% after securing a crucial patent for its biomarker-based system that evaluates progression risk in Barrett’s esophagus and esophageal ...

BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States Study shows >95% success rate, validating ...

New Data at AFS 2024 Demonstrates the Strength of Castle Biosciences’ TissueCypher® Test in Independently Predicting Risk of Developing Esophageal Cancer, Guiding Risk-Aligned Management Decisions for ...